Aaron Lesher to Immunotherapy, Adoptive
This is a "connection" page, showing publications Aaron Lesher has written about Immunotherapy, Adoptive.
Connection Strength
0.076
-
CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting. Cancer Immunol Immunother. 2010 Jun; 59(6):851-62.
Score: 0.076